Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jun 17:3:27.
doi: 10.1186/1746-1596-3-27.

Sodium polystyrene sulfonate (Kayexalate) aspiration

Affiliations

Sodium polystyrene sulfonate (Kayexalate) aspiration

Luis F Gonzalez-Cuyar et al. Diagn Pathol. .

Abstract

In this short report we illustrate a case of extensive sodium polystyrene sulfonate (SPS) aspiration as an immediate cause of death in a terminally ill patient. SPS is a cation exchange resin utilized to decrease potassium levels in patients with renal failure. When administered rectally in conjunction with sorbitol, colonic necrosis and perforation have been documented. On the other hand, oral administration can be complicated by aspiration, especially in very ill or debilitated patients. In our current report, histological examination of a patient who aspirated SPS shows multiple polygonal to amorphous basophilic crystalline particles deposited intraalveolarly. The purpose of our report is to familiarize pathologists with the histologic features of this rare iatrogenic complication of therapy for hyperkalemia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A – Medium power magnification demonstrating purple polygonal intraalveolar kayexalate crystals on a background of emphysematous changes. Scale bar 1000 μm. B – High power magnification showing the SDS crystals in high detail measuring up to 60 μm as well as smaller amorphous ones. Scale bar 20 μm.

Similar articles

Cited by

References

    1. Gerstman BB, Platt R. Use of sodium polystyrene sulfonate in sorbitol in the United States, 1985–1989. Am J Kidney Dis. 1991;18:619–20. - PubMed
    1. Osawa A, Okoshi M, Higuchi J, Yamayoshi W. [Treatment of hyperkalemia in renal insufficiency with cation exchange resin. Experience with use of sodium polystyrene sulfonate] Hinyokika Kiyo. 1969;15:645–51. - PubMed
    1. Takasu T. [Treatment of hyperkalemia associated with renal insufficiency – clinical effects and side reactions of positive-ion-exchange resins, sodium polystyrene sulfonate (Kayexalate)] Nippon Rinsho. 1970;28:1941–6. - PubMed
    1. Linakis JG, Hull KM, Lacouture PG, Lockhart GR, Lewander WJ, Maher TJ. Sodium polystyrene sulfonate treatment for lithium toxicity: effects on serum potassium concentrations. Acad Emerg Med. 1996;3:333–7. - PubMed
    1. Linakis JG, Hull KM, Lacouture PG, Lockhart GR, Lewander WJ, Maher TJ. Enhancement of lithium elimination by multiple-dose sodium polystyrene sulfonate. Acad Emerg Med. 1997;4:175–8. - PubMed

LinkOut - more resources